AGP Picks
View all

International Tech Times
Provided by AGP

International Tech Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 7, 2026

Kindkart appoints new CIO
9 hours ago

Kindkart appoints new CIO

Indeterminate EIN Presswire
Control4 Service Changes Guide Upgrade Planning
9 hours ago

Control4 Service Changes Guide Upgrade Planning

Indeterminate EIN Presswire
CV5 Capital Supports Growing Number of Managers Launching in Leading Cayman Fund Domicile
9 hours ago

CV5 Capital Supports Growing Number of Managers Launching in Leading Cayman Fund Domicile

Indeterminate EIN Presswire
T al Cubo y Tabuga llevan a la televisión dominicana un ciclo formativo sobre IA en la educación
10 hours ago

T al Cubo y Tabuga llevan a la televisión dominicana un ciclo formativo sobre IA en la educación

Indeterminate EIN Presswire
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity
an hour ago

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Indeterminate GlobeNewswire
Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
an hour ago

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

Indeterminate GlobeNewswire
Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist
2 hours ago

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

Indeterminate GlobeNewswire
Tabuga and Chile's National Center for Artificial Intelligence bring an educational AI series to Dominican television
17 hours ago

Tabuga and Chile's National Center for Artificial Intelligence bring an educational AI series to Dominican television

Indeterminate EIN Presswire
Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026
14 hours ago

Astrall Dynamics Unveils Integrated Quadruped Firefighting Robot Hypertron-T01 at INTERSCHUTZ 2026

Indeterminate GlobeNewswire
Astrall Dynamics presenterer den integrerte firbente brannslokkingsroboten Hypertron-T01 ved INTERSCHUTZ 2026
14 hours ago

Astrall Dynamics presenterer den integrerte firbente brannslokkingsroboten Hypertron-T01 ved INTERSCHUTZ 2026

Indeterminate GlobeNewswire
Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000
Jun. 7, 2026

Crypto News Today: AlphaPepe Presale Hits 9300 Holders While Bitcoin Price Prediction Targets $50,000

Indeterminate GlobeNewswire

Share this page:

Sign up for:

International Tech Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.